- Report
- October 2024
- 181 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- February 2025
- 134 Pages
Global
From €2847EUR$2,999USD£2,402GBP
- Report
- March 2025
- 288 Pages
Global
From €5316EUR$5,600USD£4,484GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- June 2024
- 175 Pages
Global
From €2373EUR$2,500USD£2,002GBP
- Report
- September 2024
- 200 Pages
Global
From €4698EUR$4,949USD£3,963GBP
- Report
- October 2024
- 189 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- November 2024
- 110 Pages
Global
From €5649EUR$5,950USD£4,765GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- December 2024
- 200 Pages
Global
From €3560EUR$3,750USD£3,003GBP
- Report
- October 2024
- 192 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 189 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- August 2024
- 100 Pages
Global
From €5649EUR$5,950USD£4,765GBP
- Report
- December 2024
- 100 Pages
Global
From €5649EUR$5,950USD£4,765GBP
- Report
- August 2024
- 142 Pages
Global
From €2847EUR$2,999USD£2,402GBP
- Report
- March 2025
- 120 Pages
Global
From €5316EUR$5,600USD£4,484GBP
- Report
- March 2025
- 97 Pages
Global
From €5316EUR$5,600USD£4,484GBP
- Report
- March 2025
- 134 Pages
Global
From €5316EUR$5,600USD£4,484GBP
- Report
- October 2024
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP

The Artificial Organ market is a subset of the Biomaterials industry, which focuses on the development of materials for use in medical applications. Artificial organs are designed to replace or supplement the function of a damaged or missing organ, and can be made from a variety of materials, including polymers, metals, and ceramics. These materials are chosen for their biocompatibility, durability, and ability to interact with the body's natural systems.
The Artificial Organ market is driven by advances in medical technology, as well as the increasing prevalence of chronic diseases and organ failure. The market is expected to grow in the coming years, as more people seek out treatments for their conditions.
Companies in the Artificial Organ market include Abiomed, SynCardia Systems, and WorldHeart Corporation. Show Less Read more